Malnutrition with Low Muscle Mass Is Common after Weaning off Home Parenteral Nutrition for Chronic Intestinal Failure
- PMID: 36678209
- PMCID: PMC9860702
- DOI: 10.3390/nu15020338
Malnutrition with Low Muscle Mass Is Common after Weaning off Home Parenteral Nutrition for Chronic Intestinal Failure
Abstract
The differences in outcomes after weaning off intravenous support (IVS) for chronic intestinal failure (IF) are unclear. Adult IF patients who are weaned off IVS at a tertiary care center (June 2019−2022) were included in this study, and nutritional and functional markers were assessed before, during, and after weaning. Short bowel syndrome (SBS) was present in 77/98 of the IF patients, with different outcomes according to the final anatomy. The body weight and the BMI increased during IVS in those with a jejunocolonic (JC) anastomosis (p < 0.001), but weight loss was significant during follow-up (p < 0.001). Malnutrition was present in >60%, with a reduced muscle mass, which was found using bioelectrical impedance analysis (BIA), in >50% of SBS-JC patients. Although reduced hand-grip strength and sarcopenia were less common, the muscle quality, or phase angle (BIA), decreased during follow-up, also correlating with serum albumin and muscle mass (p ≤ 0.01). The muscle quality and albumin were low in the patients restarting IVS, which was only the case with ≤60 cm of small bowel. Closer follow-up and earlier treatment with teduglutide (TED) should be considered in these patients, as none of the TED-treated patients were malnourished or sarcopenic. Studies on the potential benefits of nutritional and physical interventions for low muscle mass and associations with outcomes are needed in chronic IF patients.
Keywords: intestinal failure; malnutrition; parenteral nutrition; sarcopenia; short bowel syndrome; teduglutide.
Conflict of interest statement
F.J. has received grants/research support/honoraria or consultation fees from Baxter, Fresenius Kabi, Nestlé Health Sciences, BBraun, Theradial, mobile3e Consulting, Carembouche, NPS Pharmaceuticals, Shire, Takeda, Therachon, VectivBio, and Zealand Pharma. All other authors declare no relevant conflicts of interest.
Figures



Similar articles
-
Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.Nutrients. 2022 Apr 14;14(8):1634. doi: 10.3390/nu14081634. Nutrients. 2022. PMID: 35458196 Free PMC article.
-
Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.Nutr Clin Pract. 2024 Feb;39(1):141-153. doi: 10.1002/ncp.11015. Epub 2023 Jun 9. Nutr Clin Pract. 2024. PMID: 37294295 Review.
-
Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.Clin Nutr. 2020 Sep;39(9):2856-2862. doi: 10.1016/j.clnu.2019.12.019. Epub 2019 Dec 23. Clin Nutr. 2020. PMID: 31932048
-
Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report.Nutrition. 2023 Sep;113:112137. doi: 10.1016/j.nut.2023.112137. Epub 2023 Jun 18. Nutrition. 2023. PMID: 37481817
-
Management of Short Bowel Syndrome (SBS) and Intestinal Failure.Dig Dis Sci. 2023 Jan;68(1):29-37. doi: 10.1007/s10620-022-07760-w. Epub 2022 Nov 25. Dig Dis Sci. 2023. PMID: 36434372 Review.
Cited by
-
Fecal microbiota transplantation in a rodent model of short bowel syndrome: A therapeutic approach?Front Cell Infect Microbiol. 2023 Mar 3;13:1023441. doi: 10.3389/fcimb.2023.1023441. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36936775 Free PMC article.
-
Identification of key factors for malnutrition diagnosis in chronic gastrointestinal diseases using machine learning underscores the importance of GLIM criteria as well as additional parameters.Front Nutr. 2024 Dec 12;11:1479501. doi: 10.3389/fnut.2024.1479501. eCollection 2024. Front Nutr. 2024. PMID: 39726873 Free PMC article.
-
Management Patterns of Teduglutide Use in Short Bowel Syndrome: A Survey of 70 Healthcare Professionals.Nutrients. 2024 Nov 1;16(21):3762. doi: 10.3390/nu16213762. Nutrients. 2024. PMID: 39519595 Free PMC article.
References
-
- Pironi L., Arends J., Bozzetti F., Cuerda C., Gillanders L., Jeppesen P.B., Joly F., Kelly D., Lal S., Staun M., et al. ESPEN guidelines on chronic intestinal failure in adults. Clin. Nutr. 2016;35:247–307. - PubMed
-
- Pironi L., Steiger E., Joly F., Wanten G.J.A., Chambrier C., Aimasso U., Sasdelli A.S., Szczepanek K., Jukes A., Theilla M., et al. Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure. Gut. 2020;69:1787–1795. doi: 10.1136/gutjnl-2018-318172. - DOI - PubMed
-
- Pironi L., Konrad D., Brandt C., Joly F., Wanten G., Agostini F., Chambrier C., Aimasso U., Zeraschi S., Kelly D., et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey. Clin. Nutr. 2018;37:728–738. doi: 10.1016/j.clnu.2017.04.013. - DOI - PubMed
-
- Pironi L., Steiger E., Joly F., Jeppesen P.B., Wanten G., Sasdelli A.S., Chambrier C., Aimasso U., Mundi M.M., Szczepanek K., et al. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey. Clin. Nutr. ESPEN. 2021;45:433–441. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous